News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

Opinion|Videos|November 25, 2025

Understanding Elinzanetant’s Impact on VMS and Sleep Health

Author(s)Fiona C. Baker, PhD

Episodes in this series

1 expert is featured in this series.

EP. 1 Clinical Implications of Vasomotor Symptoms and Sleep Disturbance in Midlife Women

1 expert is featured in this series.

EP. 2 Understanding Elinzanetant’s Impact on VMS and Sleep Health

1 expert is featured in this series.

EP. 3 The NIRVANA Study’s Focus on VMS and Sleep Improvement

1 expert is featured in this series.

EP. 4 NIRVANA Study Findings on Early Onset of VMS and Sleep Relief

1 expert is featured in this series.

EP. 5 Integrating Patient Reported Outcomes to Capture Meaningful Clinical Benefit

1 expert is featured in this series.

EP. 6 Comparing Elinzanetant With Current Options for VMS and Sleep Management

1 expert is featured in this series.

EP. 7 Why Combined Treatment of VMS and Sleep Matters for Patient Satisfaction

1 expert is featured in this series.

EP. 8 Integrating Evidence to Enhance Treatment Approaches for VMS and Sleep

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Joy Baker, MD, talks zuranolone's onset for postpartum depression

Joy Baker, MD, talks zuranolone's onset for postpartum depression

ByJoshua Fitch, Senior Editor ,Joy Baker, MD, OBGYN, FACOG, PMH-C, C-EFM, MT(ASCP)

July 30th 2026

Bacterial vaginosis independently associated with increased STI co-infection | Image credit: stock.adobe.com

Bacterial vaginosis independently associated with increased STI co-infection

ByJoshua Fitch, Senior Editor

July 30th 2026

Michael Reed, MD, MSCP, on how a sexual health framework legitimizes women's concerns

Michael Reed, MD, MSCP, on how a sexual health framework legitimizes women's concerns

ByJoshua Fitch, Senior Editor ,Michael A. Reed, MD, MSCP

July 29th 2026

New fertility tool to help determine chances of successful IVF launches | stock.adobe.com.

New fertility tool to help determine chances of successful IVF launches

ByJoshua Fitch, Senior Editor

July 29th 2026

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

ByJoshua Fitch, Senior Editor

July 29th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

FDA approves norelgestromin and ethinyl estradiol transdermal patch for contraception

Natural Cycles receives FDA clearance for AI-powered fertility algorithm

Bacterial vaginosis independently associated with increased STI co-infection

Joy Baker, MD, talks zuranolone's onset for postpartum depression

New fertility tool to help determine chances of successful IVF launches